One in Two Births by Caesarean: Is Induction the Main Villain?

In just five years, England’s caesarean rate has moved from roughly one in three births to almost one in two. Planned and emergency caesareans have both risen, nudging England up the international league table in a way not seen in most comparable Western European countries. The curve is now familiar from headlines and official reports: more babies born in theatre, fewer spontaneous births on labour wards. What the national datasets do not yet show as clearly is how much of that curve actually runs through our induction of labour pathways [1].

The Missing Link in Caesarean Data

On paper, mode of birth statistics tell us how many babies are born vaginally, how many by planned caesarean, and how many in an emergency [1,2]. They do not, however, distinguish between an emergency caesarean after a long, exhausting induction and an emergency operation in a woman who never entered an induction pathway at all [1]. Nor do they show how many “emergency” procedures were, in practice, accelerated planned caesareans brought forward because the clinical picture deteriorated before the booked date [1]. From a data perspective, induction remains largely a black box: we can see the outcomes, but not the routes women took to get there [1,2].

On the ground, midwives and obstetricians describe a different layer of the same story [3]. Over the last decade, induction of labour has shifted from selected high‑risk cases to something much closer to a default pathway for a growing proportion of women, with around one in three births now induced [2,3]. Non‑evidence‑based policies may creep in at the edges, local thresholds for “post‑dates” or “big baby” broaden, and caution in the face of litigation nudges more women towards early intervention [2,5].

Alongside this, teams report induction nights filled with painful, irregular contractions, repeated examinations and continuous monitoring, often ending in theatre despite everyone’s best efforts [2,5]. For women, that can feel less like a carefully negotiated plan and more like a long corridor lined with interventions, with the caesarean door at the end [2,5].

Is Induction Really to Blame?

So is induction the main villain behind England’s caesarean surge? That would be too easy – and misleading [1,2]. Maternal age, BMI, co‑morbidities, multiple pregnancy, previous caesareans, staffing pressures and wider system anxiety all matter. But if we are serious about “rethinking induction of labour” and its impact on caesarean section rate, we cannot sidestep the true story and keep treating induction as an invisible prelude in the national caesarean narrative [1,2,4]. The point is not to demonise induction, but to ask harder, more specific questions about how our current pathways are designed and what they are doing [2,3,4].

The first question for any unit is simple: what proportion of emergency caesareans follows an induction pathway, and how is failed induction defined [2,3]? Not in abstract, but in their own data over the last few years. The second is: how is that pathway defined? Who is selected for induction, at what gestation, and under which indications [2,3]? What mix of pharmacological and mechanical methods is used, and with what expectations about time, pain, mobility and monitoring [2,3,4]? At what point does the team decide that the induction has had a fair trial, and how clearly is that threshold explained to the woman from the outset [2,3]? Without this level of audit, “failed induction” easily becomes a catch‑all label that hides more than it reveals [2,3,4].

Beyond the Caesarean Rate: Women's Experience Matters

Earlier in this series, we explored how mechanical cervical ripening can give teams time and flexibility in outpatient settings, and how women describe better nights when contractions are fewer, sleep is possible and movement is allowed [4]. We also asked why a woman with a healthy baby might still call her induction a terrible experience: what women remember is often pain, loss of control, confusion and the sense that decisions were made around them rather than with them [5]. Those questions now sit uncomfortably alongside the new caesarean figures [1,2]. Rising intervention rates and poor experience are no longer separate concerns – they are two sides of the same coin [2,5].

In this context, mechanical, non‑pharmacological cervical ripening deserves to be part of that conversation – not as a headline solution, but as one of the tools that make induction calmer and more predictable [3,4]. Synthetic osmotic dilators and other mechanical methods offer a way to ripen the cervix predictably, with fewer uterine contractions overnight and without adding another pharmacological layer to an already complex birth journey [3,4]. Importantly, they have been tested not only in general term inductions, but also in women with previous caesarean scars, with reassuring results for vaginal birth rates and uterine safety [6]. That does not make them a magic solution – inductions can, and do, still end in caesareans [6]. But it does mean units can think more creatively about how to build induction pathways that are less exhausting and more transparent [3,4].

Moving Induction Out of the Shadows

The real opportunity is to move away from a narrative in which induction is either “the villain” or “the saviour”. Instead, we can treat it as a powerful tool that needs careful boundaries [2,3,4]. That means agreeing, at unit level, on what constitutes a fair trial of induction, how women are counselled about the chances of vaginal birth versus caesarean, and how different methods are chosen in line with both evidence and the woman’s preferences [2,3,4]. It also means accepting that some women will reasonably prefer an elective caesarean to a high‑intensity induction with a significant chance of theatre at the end – and being honest about that trade‑off [2,5].

One in two births by caesarean is not just a statistic; it is a signal that the balance between physiological birth and operative delivery has shifted in ways that will shape the skills of the next generation of midwives and obstetricians [1,2]. If we want that shift to be intentional rather than accidental, we need to move induction of labour out of the shadows and into the audit room [2,3,4].

In your unit, do you know how many of your emergency caesareans start life as an induction – and what your induction pathway would look like if the aim were fewer operations and better experiences, without compromising safety [2,3,4]?

For a wider conversation on the pressures reshaping UK induction pathways, the Induction: Labour of Love podcast features candid discussions between midwives and obstetricians navigating these very challenges. Further clinical evidence and resources are available at dilapan.com.

References

1. Ambia J, Alderdice F, Knight M, Rowe R, Sanders J, Carson C. Short Report: International comparison of caesarean birth rates, 2020–2025. National Perinatal Epidemiology Unit, University of Oxford; 2026. Available at: https://www.npeu.ox.ac.uk/caesarean-birth-rates
2. National Maternity and Perinatal Audit (NMPA). Clinical Report 2022–2023. HQIP / Royal College of Obstetricians and Gynaecologists; 2025. Available at: https://maternityaudit.org.uk/FilesUploaded/Ref%20336%20NMPA%20Clinical%20Report_2022.pdf
3. National Maternity and Perinatal Audit (NMPA). Induction of Labour Snapshot Audit 2011/12–2023/24. NMPA; 2024. Available at: https://maternityaudit.org.uk/FilesUploaded/ref%20546%20IOL%20Snapshot%20Report_VF%20(2).pdf
4. Quigley MA et al. Use of induction of labour and emergency caesarean section and perinatal outcomes in English maternity services: a national hospital‑level study. BJOG. 2022;129(9):1440–1450. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9543153/
5. Wilkinson E. More than half of births in Great Britain now have medical intervention, report finds. BMJ. 2025;390:r1923. Available at: https://www.bmj.com/content/390/bmj.r1923
6. Ben‑Aroya Z et al. Pregnancy outcomes of induced labour in women with previous caesarean section: a systematic review and meta‑analysis. Arch Gynecol Obstet. 2015;291(5):969–978. Available at: https://pubmed.ncbi.nlm.nih.gov/25178187/

‍